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Abstract Hexokinase and glucose-6-phosphate dehydrogenase
activities were increased in Xenopus laevis oocytes by micro-
injection of commercial pure enzymes. The effect of increased
fractional activities on glycogen synthesis or on the production of
14CO2 (the oxidative portion of the pentose phosphate pathway)
was investigated by microinjection of [1-14C]glucose and
measurements of the radioactivity in glycogen and CO2. Control
coefficients calculated from the data show that hexokinase plays
an important role in the control of glycogen synthesis (control
coefficient = 0.7) but its influence on the control of the pentose
phosphate pathway is almost nil (control coefficient =30.01).
Glucose-6-phosphate dehydrogenase injections did not affect the
production of 14CO2 by the pentose phosphate pathway,
indicating that other factors control the operation of this
pathway. In addition, an almost null control of this enzyme on
glycogen synthesis flux was observed. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
In metabolic control analysis the control properties of a
metabolic pathway are quantitatively expressed in terms of
control coe⁄cients, each de¢ned as the fractional change in
a systemic variable that results from an in¢nitesimal fractional
change in the rate of an enzyme activity [1,2]. Control coef-
¢cients have been measured in di¡erent metabolic systems by
indirect methods, e.g. from measurements of enzyme kinetic
parameters and metabolite levels as ¢rst applied by Groen and
coworkers [3,4] or by direct methods through the modi¢cation
of the amount or activity of an enzyme [1].
Most measurements of control coe⁄cients have been per-
formed using titration with speci¢c inhibitors [5^10] or titra-
tion with puri¢ed enzymes using tissue homogenates [11,12],
as it is di⁄cult to change the activity of an enzyme inside a
cell. Manipulation at the genetic level, resulting in overexpres-
sion or deletion of an enzyme activity, is now possible and in
principle is a powerful tool for changing an enzyme activity
and computing the control coe⁄cient, e.g. a high control co-
e⁄cient has been reported for glucokinase in hepatocytes us-
ing adenovirus-mediated overexpression of the enzyme [13].
However, as summarized by Bailey [14], even in cases in which
only one gene has been cloned into cells in an expression
vector, a number of other proteins exhibit altered levels.
Thus, several examples of two-dimensional electrophoresis
and proteome analysis have been reported that clearly show
that any change, including ones thought to be ‘neutral’,
changes the relative levels of several, often many, individual
proteins [14^18].
Amphibian oocytes may qualify as an ideal model system
for in vivo measurements of control coe⁄cients, as fractional
changes of the rate of an enzyme can be accomplished by
microinjection of the enzyme, ensuring that the necessary con-
dition to measure a control coe⁄cient is ful¢lled: only one
enzyme concentration is altered inside the cell. The fully
grown oocyte of Xenopus laevis is a large cell, making manip-
ulations easy and allowing injection of intermediates and larg-
er biomolecules (enzymes, antibodies or mRNA). In frog oo-
cytes, microinjected labelled glucose is incorporated into
glycogen [19] and, to a minor extent, released as CO2 through
the pentose phosphate pathway only, since [6-14C]glucose does
not produce 14CO2 [20^22].
In the research now described, several titers of hexokinase
and glucose-6-phosphate dehydrogenase were microinjected
into Xenopus oocytes, followed by labelled glucose microinjec-
tion and measurements of labelled glycogen and CO2. From
these experimental measurements we have computed the con-
trol coe⁄cients and quantitatively assessed the potential of
hexokinase and glucose-6-phosphate dehydrogenase to con-
trol glycogen synthesis and the oxidative arm of the pentose
phosphate pathway £uxes in Xenopus oocytes and therefore to
contribute to a greater understanding of the control of glucose
metabolism in these cells. Also, we show that the amphibian
oocyte is an ideal test tube for studies of control of metabo-
lism and to test the feasibility of measuring control coe⁄cients
in vivo by e⁄ciently perturbing the level of each enzyme in-
dependently.
2. Materials and methods
2.1. Materials
[1-14C]Glucose was purchased from Amersham. Just before each
experiment an aliquot containing the desired radioactivity was evapo-
rated under N2 to remove ethanol and resuspended on modi¢ed
Barth’s saline [23]. Hexokinase and glucose-6-phosphate dehydrogen-
ase were from Sigma Chemical Co. (St. Louis, MO, USA). All other
reagents were of analytical grade.
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2.2. Cells
Stage VI oocytes of X. laevis females were obtained by surgical
excision under low temperature anesthesia and freed from membranes
by blunt dissection with jeweller’s forceps.
2.3. Preparation of oocyte extracts
One gram of oocytes (about 50 oocytes) was homogenized in 3 ml
50 mM Tris^HCl bu¡er pH 7.4 containing 0.3 mg/ml trypsin inhib-
itor. The homogenate was sonicated for 5 min and clari¢ed by ultra-
centrifugation during 1 h at 100 000Ug and ¢ltered through 0.2 Wm
¢lters. Hexokinase and glucose-6-phosphate dehydrogenase activities
were measured in the extracts.
2.4. Measurement of enzyme activities
Glucose-6-phosphate dehydrogenase activity was measured as de-
scribed by Tian et al. [24] using 2 mM glucose-6-phosphate and
0.5 mM NADP in a 50 mM Tris^HCl bu¡er pH 7.6 at 37‡C. The
reduction of NADP, which is directly proportional to glucose-6-
phosphate dehydrogenase activity, was followed by the increase in
absorbance at 340 nm using a spectrophotometer (Shimadzu Cell
Positioner CPS-260). Activity was expressed as units de¢ned as
Wmol/min in the speci¢ed conditions.
Hexokinase activity was measured at 340 nm by a coupled assay
with glucose-6-phosphate dehydrogenase as described by Ureta [25].
The assay mixture contained 10 mM glucose, 2 mM ATP-Mg, 1 mM
NADP and 1 mU of glucose-6-phosphate dehydrogenase in a 50 mM
HEPES bu¡er pH 7.4.
2.5. Metabolic labelling
Oocytes were injected essentially as described by Ureta and Radoj-
kovic [26] with 50 nl of Barth’s saline solution alone or supplemented
with a measured amount of either yeast hexokinase (type C-300, Sig-
ma) or yeast glucose-6-phosphate dehydrogenase (type IX, Sigma).
Enough enzyme was injected to increase the endogenous activity
(measured in crude extracts as described above) by a factor of 1, 2,
3, 4, 5 or higher (up to 20 in some experiments). After about 60 min
to allow for di¡usion of the enzymes, the oocytes were reinjected with
50 nl of saline containing 6 nmol of [1-14C]glucose (about 10 000 cpm/
nmol) diluted in Barth’s saline solution. Groups of four oocytes in the
same experimental condition were then incubated at 22‡C in 100 Wl
Barth’s saline for 15 min. Incubation was performed in sealed tubes
with a continuous £ow of O2. 14CO2 was collected in vials containing
100 Wl 0.3 M NaOH, 5% Triton X-100. Radioactivity in the vials was
measured in a Wallac liquid scintillation spectrometer with 10 ml
OptiPhase HiSafe (Wallac Scintillation Products).
Glucose incorporation into glycogen was measured by the proce-
dure described by Chan and Exton [27]. Each oocyte was individually
digested in 200 Wl of 30% KOH at 100‡C for 30 min. The whole
incubation mixture was then applied to small squares (2U2 cm) of
ET31 Whatman ¢lter paper and washed once during 30 min in 66%
(v/v) ethanol at 320‡C, twice during 15 min in 66% (v/v) ethanol at
room temperature, and brie£y in acetone. Filters were dried in a
microwave oven and the radioactivity measured in a scintillation
counter using 0.5% (w/v) 2,5-diphenyloxazole in toluene as scintillant.
2.6. Estimation of £ux control coe⁄cients







where J is the £ux of interest and e is the activity of the enzyme
[28,29]. The £ux control coe⁄cients are de¢ned for a reference
steady-state £ux that in general corresponds to the unperturbed sys-
tem. They were estimated by two methods, either from the slope of
log £ux versus log enzyme activity, as in our experiments (see below) a
linear dependence was obtained in the range of enzyme activities used,
or by means of Small and Kacser’s method [30] for large changes in
enzyme activities. The £ux control coe⁄cient according to the latter













where Ji and Jf are the initial and ¢nal metabolic £ux respectively and
ei and ef are the ¢nal and initial enzyme activities and CJe is the £ux
control coe⁄cient at the initial steady state. Ji and ei were measured
according to the methods described above under basal conditions and
Jf and ef were measured after microinjecting the oocyte with an excess
of the appropriate enzyme. As the control coe⁄cient is a dimension-
less measure, the enzyme activities may be expressed using arbitrary
units, and in our case they are expressed as times the endogenous
activities.
3. Results
3.1. Steady-state attainment of glycogen and CO2 formation
£uxes from glucose
Measurement of £ux control coe⁄cient with respect to any
enzyme by any method requires that the basal £ux of the
system be at steady state. In order to determine the time
interval in which this condition is ful¢lled, time courses of
glycogen synthesis and CO2 formation were measured in oo-
cytes microinjected with [1-14C]glucose. Incorporation of label
into glycogen and CO2 was measured at di¡erent times from 0
to 30 min. The time course of glycogen and CO2 formation
was linear between 0 and 30 min (Fig. 1). Accordingly, all
measurements were performed at 15 min after glucose injec-
tion.
3.2. Endogenous levels of hexokinase and glucose-6-phosphate
dehydrogenase activities
The endogenous activities of oocyte hexokinase and glu-
cose-6-phosphate dehydrogenase were 80 þ 7 WU/oocyte for
hexokinase and 160 þ 14 WU/oocyte for glucose-6-phosphate
dehydrogenase. The resulting values were used to calculate
the amounts of hexokinase or glucose-6-phosphate dehydro-
genase to be microinjected at the levels indicated below.
3.3. Control of hexokinase on glycogen synthesis and CO2
production £uxes
To determine the relationship between glycogenic £ux and
hexokinase activity, hexokinase was microinjected in su⁄cient
amounts to increase the enzyme activity from the endogenous
value inside the oocytes by a factor in the range 2^5 (Fig. 2,
left). A control coe⁄cient value of 0.7 for hexokinase on
glycogen £ux was determined from the slope of log £ux versus
log hexokinase activity (inset in Fig. 2, left), which describes
the sensitivity of glycogen synthesis to hexokinase. The con-
trol coe⁄cient for the experiments in Fig. 2, left, was also
estimated by the method of Small and Kacser [30] for large
changes according to Eq. 2 for the di¡erent hexokinase titers;
values between 0.7 and 0.8 were obtained for any of the titers
considered as the ¢nal enzyme activity, showing the agreement
between these two methods. To minimize possible errors in
estimating the endogenous hexokinase activity, microinjection
of 20 times the endogenous level was performed and the con-
trol coe⁄cient was estimated by the method of large changes
(Eq. 2). A value of 0.7 for the control coe⁄cient was obtained
showing the validity of the in vivo method also for a single
large change in enzyme concentration. The value of around
0.7^0.8 obtained for the control coe⁄cient is high, and indi-
cates an important role of hexokinase in controlling glycogen-
ic £ux in oocytes. It is often assumed that the log £ux versus
log enzyme dependence is linear only for small changes in
enzyme activity [1,28]. However, the data in the inset of Fig.
2, left, show a linear dependence on log £ux versus log of
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hexokinase activity over a wide range of hexokinase levels.
Thus, in this case the control coe⁄cient of hexokinase on
glycogenic £ux measured in vivo is a good predictor of the
e¡ect of large changes in hexokinase activity. The linearity is
only lost at concentrations of hexokinase activity higher than
10 times the endogenous level and the hyperbolic dependence
of £ux with regard to enzyme activity becomes apparent (data
not shown).
The same experiments were used to determine the relation
between the oxidative pentose phosphate pathway £ux (meas-
ured as 14CO2 formation from [1-14C]glucose) and hexokinase
activity (Fig. 2, right). CO2 £ux was not a¡ected by increasing
levels of hexokinase since a control coe⁄cient value of 30.01
was obtained (see inset in Fig. 2, right). Thus, even though the
conversion of glucose into glucose 6-phosphate is the ¢rst step
of the oxidative pentose phosphate pathway it appears that
glucose phosphorylation does not control the £ux of the
shunt.
3.4. Control of glucose-6-phosphate dehydrogenase on glycogen
synthesis and CO2 production £uxes
Similar experiments were performed to determine the sensi-
tivity of glycogen synthesis and oxidative pentose phosphate
pathway £uxes to increase of glucose-6-phosphate dehydro-
genase activity in vivo.
To determine the relationship between glycogen £ux and
glucose-6-phosphate dehydrogenase activity we microinjected
enough dehydrogenase to increase the endogenous values of
enzyme activity inside the oocytes by factors of 2^6 (Fig. 3,
left). The control coe⁄cient value was practically zero (0.02)
for glucose-6-phosphate dehydrogenase on glycogen £ux (in-
set in Fig. 3, left) which describes the practically null sensitiv-
Fig. 1. Time course of glycogen and CO2 labelling by oocytes microinjected with [1-14C]glucose. Oocytes were microinjected with 50 nl of
Barth’s saline solution containing 6 nmol [1-14C]glucose (V10 000 cpm/nmol). Groups of four oocytes in duplicated £asks were incubated dur-
ing the indicated times. At the end of the incubation period, glycogen was isolated and its radioactivity measured as described in Section 2.
14CO2 was measured at the end of the incubation period. Left: Incorporation of [1-14C]glucose into glycogen. Right: Production of 14CO2
from the same oocytes as in the left panel. Results are expressed as pmol of glucose equivalents in glycogen and CO2 and presented as means
þ S.E.M. of 6^8 observations.
Fig. 2. E¡ect of hexokinase microinjection on [1-14C]glucose metabolism by frog oocytes. Oocytes were microinjected with 50 nl of Barth’s solu-
tion containing the desired amounts of enzyme such as to increase the hexokinase activity inside the cells by 2-, 3-, 4- or 5-fold. After incuba-
tion during 1 h, each oocyte was reinjected with 50 nl of saline containing 6 nmol [1-14C]glucose (V10 000 cpm/nmol) and further incubated
for 15 min. At the end of the second incubation period, radioactivity in glycogen and CO2 was measured as described in Section 2. Left: Incor-
poration of [1-14C]glucose into glycogen. Right: Production of 14CO2 from the same oocytes as in the left panel. Results are expressed as pmol
of glucose equivalents in glycogen and CO2 and presented as means þ S.E.M. of 6^8 observations. Insets show the same data expressed as log^
log graphs. Values in parentheses indicate the control coe⁄cients determined as the slope of the linear ¢tting.
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ity of glycogen synthesis to the activity of the dehydrogenase.
The relationship between the oxidative pentose phosphate
pathway £ux and the glucose-6-phosphate dehydrogenase ac-
tivity was determined by measuring 14CO2 formation from
[1-14C]glucose (Fig. 3, right). A value very close to zero
(30.05) for the control coe⁄cient of glucose-6-phosphate de-
hydrogenase on the oxidative pentose phosphate pathway £ux
(inset in Fig. 3, right) was obtained, which describes the null
sensitivity of the shunt to glucose-6-phosphate dehydrogenase.
It should be noted that even though glucose-6-phosphate
dehydrogenase is the ¢rst enzyme of the oxidative pentose
phosphate pathway and is considered in practice to be an
irreversible step, it does not control the £ux of the pathway
at all. In a linear chain such as the oxidative pentose phos-
phate pathway, the enzymes following an irreversible step
must have a control coe⁄cient value of zero if there is no
feedback inhibition [1]. Thus, as neither hexokinase nor glu-
cose-6-phosphate dehydrogenase exerts any control on the
pathway £ux, the following enzymes will have control coe⁄-
cients equal to zero. Therefore, we conclude that in oocytes
the oxidative pentose phosphate pathway is not controlled at
the level of enzyme activities.
4. Discussion
The results described in this paper con¢rm that microinjec-
tion of enzymes in oocytes is a very powerful tool for in vivo
titration of enzymes and show that it permits control coe⁄-
cients to be measured in vivo with con¢dence that only one
enzyme level has been changed. Overexpression of enzymes by
genetic manipulation does not ensure that the expression of
other proteins has not also internally changed to compensate
for the perturbation [14].
Surprisingly, the control coe⁄cient of hexokinase on glyco-
gen synthesis £ux is constant in a wide range of concentra-
tions (from one to ¢ve times the endogenous levels) showing
that control coe⁄cients can in this case have a predictive
value on the behavior of the system as a response to large
changes in hexokinase levels. Thus, although theoreticians
have often pointed out that the predictive value of control
coe⁄cients is limited only to in¢nitesimal changes around
the operational steady state [1,2], it has been shown in this
in vivo example that control coe⁄cients can be constant over
a large range of enzyme levels.
The lack of e¡ect of microinjected glucose-6-phosphate de-
hydrogenase on the £ux of the oxidative arm of the pentose
phosphate pathway was not unexpected. The activity of the
enzyme in oocytes of the frog Caudiverbera has a potential
Vmax of about 12 600 pmol/min/oocyte but in vivo measure-
ments at saturating levels of labelled glucose or glucose
6-phosphate indicate a maximal production of 14CO2 of at
most 5 pmol/min/oocyte [22]. Therefore, the low in vivo ac-
tivity of the pentose phosphate pathway in amphibian oocytes
is not due to a low activity of the dehydrogenases but to other
factors. Preller et al. [22] conclude that the unfavorable
NADP/NADPH ratio e¡ectively limits the operation of the
pentose phosphate pathway as direct microinjection of
NADP raises 10-fold the production of 14CO2 from labelled
glucose.
The results presented in this paper on the lack of e¡ect on
oxidative pentose phosphate pathway of both hexokinase and
glucose-6-phosphate dehydrogenase together with previous re-
sults of Preller et al. [22] in Caudiverbera are further evidence
of the potential for physiological levels of NADPH demand to
exert control over oxidative pentose phosphate pathway £ux.
An alternative explanation for the lack of e¡ect of hexokinase
on the oxidative pentose phosphate pathway £ux is that the
glucose 6-phosphate pool produced by the exogenous hexoki-
nase does not mix with that available for the pentose phos-
phate pathway.
It should be stressed that hexokinase and glucose-6-phos-
phate dehydrogenase are enzymes with high homology
throughout eukaryotes. Yeast hexokinase and glucose-6-phos-
phate dehydrogenase were used instead of X. laevis enzymes
because it was easier to obtain the proper amounts to carry
out microinjection studies, particularly in the case of hexoki-
nase. The use of commercial enzymes from other sources is
acceptable since our aim was to modify the hexokinase activ-
ity inside the oocyte which can be accomplished by injection
of suitable available enzymes. The fact that a clear-cut e¡ect
Fig. 3. E¡ect of glucose-6-phosphate dehydrogenase (G6PDH) microinjection on [1-14C]glucose metabolism by frog oocytes. Oocytes were mi-
croinjected with 50 nl of Barth’s saline solution containing the desired amounts of enzyme such as to increase the G6PDH activity inside the
cells by 2-, 3-, 4- 5- or 6-fold. After incubation during 1 h the same treatment as in Fig. 2 was performed. Left: Incorporation of [1-14C]glucose
into glycogen. Right: Production of 14CO2 from the same oocytes as in the left panel. Results are expressed as pmol of glucose equivalents in
glycogen and CO2 and presented as means þ S.E.M. of 6^8 observations. Insets show the same data expressed as log^log graphs. Values in pa-
rentheses indicate the control coe⁄cients determined as the slope of the linear ¢tting.
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was indeed observed is consistent with the conclusion that the
injected yeast hexokinase was able to use the metabolic set-up
of the oocyte (i.e. endogenous ATP and the supplied glucose)
and that the pool of glucose 6-phosphate thereby produced
was directed to glycogen, the ¢nal product of the pathway. In
fact, the main point to measure a control coe⁄cient is that the
activity of the enzyme inside the cell increases whereas other
enzyme activities are not altered.
The application of control analysis to studies on metabolic
regulation challenged the idea of the ‘rate-limiting step’ at the
beginning of a metabolic pathway and has shown that it is not
a general rule [31]. Our results show that the oxidative pentose
phosphate pathway is another exception to this rule.
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